Usana Health Sciences
USNA
192 hedge funds and large institutions have $871M invested in Usana Health Sciences in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 76 reducing their positions, and 24 closing their positions.
115% more call options, than puts
Call options by funds: $758K | Put options by funds: $353K
4% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 24
0% more funds holding
Funds holding: 192 → 192 (0)
0.8% less ownership
Funds ownership: 57.33% → 56.54% (-0.8%)
2% less capital invested
Capital invested by funds: $884M → $871M (-$13.7M)
24% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 76
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
CAAS Capital Management
New York
|
+$14.8M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$7.01M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$4.2M |
| 4 |
Man Group
London,
United Kingdom
|
+$4.18M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$9.37M |
| 2 |
BlackRock
New York
|
-$5.25M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
-$4.62M |
| 4 |
D.E. Shaw & Co
New York
|
-$4.39M |
| 5 |
Morgan Stanley
New York
|
-$3.91M |
USNA Hedge Fund Activity: Q3 2020 in Review
192 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2020, worth a combined $871M — down 1.6% from $884M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new USNA positions and 24 closed out — a net gain of 1 holder — while 58 added to existing stakes and 76 trimmed.
The largest buyer was CAAS Capital Management, opening a new position worth an estimated $14.8M. The largest seller was Millennium Management, cutting an estimated $9.37M.
- 192 institutional investors held Usana Health Sciences (USNA) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $871M of Usana Health Sciences stock for Q3 2020, down 1.6% quarter-over-quarter.
- 25 funds opened new Usana Health Sciences positions in Q3 2020 and 24 closed out, a net change of +1 holder.
- The largest Usana Health Sciences buyer in Q3 2020 was CAAS Capital Management, an estimated $14.8M added.
- The largest Usana Health Sciences seller in Q3 2020 was Millennium Management, an estimated $9.37M sold.
Based on aggregated 13F filings for Q3 2020.